echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Vigorously develop the scale of the Chinese medicine market or usher in a new wave of growth

    Vigorously develop the scale of the Chinese medicine market or usher in a new wave of growth

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network News on May 14 
     
    Vigorously develop traditional Chinese medicine
     
    On the afternoon of May 12, the general secretary who was inspecting in Nanyang City, Henan Province successively came to the Medical Sacred Shrine and Nanyang Medicine Yibao Wormwood Products Co.
    , Ltd.
    to learn about the development of Chinese medicine and the wormwood products industry.
     
    The general secretary said that in the past, the Chinese nation has relied on Chinese medicine to treat illnesses and save people for thousands of years.
    Especially after fighting against the new crown pneumonia epidemic, SARS and other major infectious diseases, we have a deeper understanding of the role of Chinese medicine.
    We must develop Chinese medicine, focus on interpreting the principles of Chinese medicine with modern science, and take the road of integrating Chinese and Western medicine.
     
    According to data, Chinese medicine products are mainly divided into Chinese medicinal materials, Chinese medicinal pieces and Chinese patent medicines.
    Among them, Chinese medicinal materials are primary products, and Chinese patent medicines and Chinese medicine pieces are end products that can be used directly.
     
    It is worth noting that for a long time, the state has been vigorously supporting the traditional Chinese medicine decoction pieces industry.
    The use of TCM decoction pieces is not restricted by many medical reform policies, and the development momentum is better than that of proprietary Chinese medicines.
     
    On May 13th, at the High Quality Development Forum of the Chinese Medicine Industry of the National Pharmaceutical Fair, Cyberlan learned that in recent years, the country has vigorously developed Chinese medicine and the favorable policies for Chinese medicine have blown out, such as the "Outline of the Strategic Plan for the Development of Chinese Medicine", "The Law of the People's Republic of China on Traditional Chinese Medicine", "Opinions on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine" and "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine with Characteristics.
    "
     
      Among them, the "Outline of the Strategic Planning for the Development of Traditional Chinese Medicine" clarifies the development direction and focus of my country's traditional Chinese medicine in the next 15 years, and promotes the development of Chinese medicine as a national strategy; and the "Traditional Chinese Medicine Law" is my country's first comprehensive and systematic reflection of the characteristics of Chinese medicine.
    Comprehensive laws.
     
      The growth rate of Chinese patent medicine slows down
     
      Previously, because proprietary Chinese medicines were subject to “zero mark-up” and the proportion of medicines, doctors’ prescriptions were restricted.
    Some large varieties of Chinese medicines were included in the local supplementary drug list, and the dosage restrictions were more stringent, resulting in the use of proprietary Chinese medicines in medical institutions.
    Both the amount used and the proportion dropped significantly.
     
      However, Cybelan learned at the drug fair that, up to now, many proprietary Chinese medicines have become more concerned about the transfer of approval documents, including cold, gynecological, and digestive varieties.
    Among them, cold-type Chinese patent medicines are more popular.
    Relevant sources said that the compound honeysuckle granules, Xia Sangju granules, and dandelion granules have good curative effects and the well-known varieties will be more popular.
     
      A more critical factor is the epidemic.
    Some people in the industry once told Cyberlan that the new crown epidemic has elevated the position of Chinese patent medicine, because in the first-line treatment, the epidemic has highlighted the role of Chinese medicine in the treatment of epidemic disease, which will make In the long-term plan, forward-looking pharmaceutical companies explore such products and lay out product lines.
     
      If the changes in hospital medication are not obvious enough, then pharmacies have tasted the sweetness more.
    Basic pharmacies all involved to improve the immune system of medicines , whether traditional Chinese medicine drinks, medicine will be subject to people's attention.
    For example, people over the age of 60 began to buy Chinese herbal health teas, medlar, honeysuckle, and Gynostemma pentaphyllum in pharmacies, and others consulted Cordyceps, Dendrobium and other Chinese herbal drinks for nourishing yin and nourishing lungs.
     
      Some research institutions said that in response to the pressure from medical insurance to control costs, Chinese medicine companies can transform innovative Chinese medicines and develop Chinese patent medicines with significant curative effects and fewer competing products, alleviating the pressure of competitive price reduction; transforming ordinary consumer products that are immune to medical insurance, directly avoiding medical insurance control costs Pressure: To transform into a high-quality and low-cost Chinese medicinal material manufacturer, to control costs, and to transmit pressure to lower prices upstream.
     
      Chinese medicine formula particles are good
     
      It is worth noting that the characteristic Chinese herbal medicine pieces represented by Chinese medicine formula granules is one of the development directions of Chinese medicine, because traditional Chinese medicines such as oral Chinese medicine and traditional Chinese medicine pieces are the core opportunities of current Chinese medicine-the national policy guidelines on Chinese medicine encourage traditional usage.
     
      Cyberlan learned from the above-mentioned high-quality development forum of the Chinese medicine industry that Chinese medicine formula granules do not account for the proportion of medicines, medical insurance can be reimbursed, and hospitals can make money.
    Therefore, 80% of hospitals in 2021 will very much recognize and accept such medicines; in addition, , Because most of the formula particles are directly supplied by traditional Chinese medicine factories, and there is no need for hospitals to set up equipment because of the establishment of special dispensing machines.
    Generally speaking, hospitals will prefer them.
     
      At the same time, formula granules can expand the route and scope of drug administration in the diagnosis and treatment plan, increase the diversity of doctors' treatment methods, and make it easier to carry and store, and the safety and efficacy are more guaranteed-this type of drug is compared in terms of quality control.
    Strict, strict testing of indicators such as heavy metal content, pesticide residues, microorganisms, and chemical pollution.
     
      Data show that from 2011 to 2018, my country's sales revenue of Chinese medicine formula granules increased from about 2.
    2 billion yuan to about 16.
    5 billion yuan, a growth rate that far exceeded that of ordinary Chinese medicine decoction pieces and proprietary Chinese medicines in the same period.
     
      For domestic Chinese medicine companies, the epidemic has brought opportunities for the development of Chinese medicine.
     
      China Traditional Chinese Medicine released its annual report.
    In 2020, the company's performance reached a new high.
    The positive growth in operating performance under the epidemic was mainly due to the active resumption of work and production during the epidemic and the grasp of development opportunities in the Chinese medicine industry.
    Traditional Chinese medicine formula granules are the company's core business.
    In 2020, its business turnover will be approximately 10.
    01 billion yuan, accounting for 67.
    6% of the total turnover.
    Due to the impact of the epidemic, growth has slowed down, with a year-on-year increase of 8.
    5%.
    However, during the epidemic, the company took the initiative to leverage its advantages in formula particles and increased its investment in dispensing machines and the development of medical customers.
    In the second half of the year, its operations picked up, and its turnover increased by 16.
    9% over the same period and 19.
    1% over the first half of the year.
     
      To a certain extent, now is the golden age of the development of Chinese medicine.
    The epidemic has pushed the position of Chinese medicine, and formula particles are gradually being released.
    Some pharmaceutical companies have seized the opportunity to achieve rapid growth.
    The words of the General Secretary this time are another clear signal.
    As the favorable Chinese medicine policy is gradually implemented, it is expected that the market scale will usher in a new wave of growth.
    Medical Network News on May 14 
     
      Vigorously develop traditional Chinese medicine
     
      On the afternoon of May 12, the general secretary who was inspecting in Nanyang City, Henan Province successively came to the Medical Sacred Shrine and Nanyang Medicine Yibao Wormwood Products Co.
    , Ltd.
    to learn about the development of Chinese medicine and the wormwood products industry.
     
      The general secretary said that in the past, the Chinese nation has relied on Chinese medicine to treat illnesses and save people for thousands of years.
    Especially after fighting against the new crown pneumonia epidemic, SARS and other major infectious diseases, we have a deeper understanding of the role of Chinese medicine.
    We must develop Chinese medicine, focus on interpreting the principles of Chinese medicine with modern science, and take the road of integrating Chinese and Western medicine.
     
      According to data, Chinese medicine products are mainly divided into Chinese medicinal materials, Chinese medicinal pieces and Chinese patent medicines.
    Among them, Chinese medicinal materials are primary products, and Chinese patent medicines and Chinese medicine pieces are end products that can be used directly.
     
      It is worth noting that for a long time, the state has been vigorously supporting the traditional Chinese medicine decoction pieces industry.
    The use of TCM decoction pieces is not restricted by many medical reform policies, and the development momentum is better than that of proprietary Chinese medicines.
     
      On May 13th, at the High Quality Development Forum of the Chinese Medicine Industry of the National Pharmaceutical Fair, Cyberlan learned that in recent years, the country has vigorously developed Chinese medicine and the favorable policies for Chinese medicine have blown out, such as the "Outline of the Strategic Plan for the Development of Chinese Medicine", "The Law of the People's Republic of China on Traditional Chinese Medicine", "Opinions on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine" and "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine with Characteristics.
    "
     
      Among them, the "Outline of the Strategic Planning for the Development of Traditional Chinese Medicine" clarifies the development direction and focus of my country's traditional Chinese medicine in the next 15 years, and promotes the development of Chinese medicine as a national strategy; and the "Traditional Chinese Medicine Law" is my country's first comprehensive and systematic reflection of the characteristics of Chinese medicine.
    Comprehensive laws.
     
      The growth rate of Chinese patent medicine slows down
     
      Previously, because proprietary Chinese medicines were subject to “zero mark-up” and the proportion of medicines, doctors’ prescriptions were restricted.
    Some large varieties of Chinese medicines were included in the local supplementary drug list, and the dosage restrictions were more stringent, resulting in the use of proprietary Chinese medicines in medical institutions.
    Both the amount used and the proportion dropped significantly.
     
      However, Cybelan learned at the drug fair that, up to now, many proprietary Chinese medicines have become more concerned about the transfer of approval documents, including cold, gynecological, and digestive varieties.
    Among them, cold-type Chinese patent medicines are more popular.
    Relevant sources said that the compound honeysuckle granules, Xia Sangju granules, and dandelion granules have good curative effects and the well-known varieties will be more popular.
     
      A more critical factor is the epidemic.
    Some people in the industry once told Cyberlan that the new crown epidemic has elevated the position of Chinese patent medicine, because in the first-line treatment, the epidemic has highlighted the role of Chinese medicine in the treatment of epidemic disease, which will make In the long-term plan, forward-looking pharmaceutical companies explore such products and lay out product lines.
     
      If the changes in hospital medication are not obvious enough, then pharmacies have tasted the sweetness more.
    Basic pharmacies all involved to improve the immune system of medicines , whether traditional Chinese medicine drinks, medicine will be subject to people's attention.
    For example, people over the age of 60 began to buy Chinese herbal health teas, medlar, honeysuckle, and Gynostemma pentaphyllum in pharmacies, and others consulted Cordyceps, Dendrobium and other Chinese herbal drinks for nourishing yin and nourishing lungs.
     
      Some research institutions said that in response to the pressure from medical insurance to control costs, Chinese medicine companies can transform innovative Chinese medicines and develop Chinese patent medicines with significant curative effects and fewer competing products, alleviating the pressure of competitive price reduction; transforming ordinary consumer products that are immune to medical insurance, directly avoiding medical insurance control costs Pressure: To transform into a high-quality and low-cost Chinese medicinal material manufacturer, to control costs, and to transmit pressure to lower prices upstream.
     
      Chinese medicine formula particles are good
     
      It is worth noting that the characteristic Chinese herbal medicine pieces represented by Chinese medicine formula granules is one of the development directions of Chinese medicine, because traditional Chinese medicines such as oral Chinese medicine and traditional Chinese medicine pieces are the core opportunities of current Chinese medicine-the national policy guidelines on Chinese medicine encourage traditional usage.
     
      Cyberlan learned from the above-mentioned high-quality development forum of the Chinese medicine industry that Chinese medicine formula granules do not account for the proportion of medicines, medical insurance can be reimbursed, and hospitals can make money.
    Therefore, 80% of hospitals in 2021 will very much recognize and accept such medicines; in addition, , Because most of the formula particles are directly supplied by traditional Chinese medicine factories, and there is no need for hospitals to set up equipment because of the establishment of special dispensing machines.
    Generally speaking, hospitals will prefer them.
     
      At the same time, formula granules can expand the route and scope of drug administration in the diagnosis and treatment plan, increase the diversity of doctors' treatment methods, and make it easier to carry and store, and the safety and efficacy are more guaranteed-this type of drug is compared in terms of quality control.
    Strict, strict testing of indicators such as heavy metal content, pesticide residues, microorganisms, and chemical pollution.
     
      Data show that from 2011 to 2018, my country's sales revenue of Chinese medicine formula granules increased from about 2.
    2 billion yuan to about 16.
    5 billion yuan, a growth rate that far exceeded that of ordinary Chinese medicine decoction pieces and proprietary Chinese medicines in the same period.
     
      For domestic Chinese medicine companies, the epidemic has brought opportunities for the development of Chinese medicine.
     
      China Traditional Chinese Medicine released its annual report.
    In 2020, the company's performance reached a new high.
    The positive growth in operating performance under the epidemic was mainly due to the active resumption of work and production during the epidemic and the grasp of development opportunities in the Chinese medicine industry.
    Traditional Chinese medicine formula granules are the company's core business.
    In 2020, its business turnover will be approximately 10.
    01 billion yuan, accounting for 67.
    6% of the total turnover.
    Due to the impact of the epidemic, growth has slowed down, with a year-on-year increase of 8.
    5%.
    However, during the epidemic, the company took the initiative to leverage its advantages in formula particles and increased its investment in dispensing machines and the development of medical customers.
    In the second half of the year, its operations picked up, and its turnover increased by 16.
    9% over the same period and 19.
    1% over the first half of the year.
     
      To a certain extent, now is the golden age of the development of Chinese medicine.
    The epidemic has pushed the position of Chinese medicine, and formula particles are gradually being released.
    Some pharmaceutical companies have seized the opportunity to achieve rapid growth.
    The words of the General Secretary this time are another clear signal.
    As the favorable Chinese medicine policy is gradually implemented, it is expected that the market scale will usher in a new wave of growth.
    Medical Network News on May 14 
     
      Vigorously develop traditional Chinese medicine
      Vigorously develop traditional Chinese medicine
     
      On the afternoon of May 12, the general secretary who was inspecting in Nanyang City, Henan Province successively came to the Medical Sacred Shrine and Nanyang Medicine Yibao Wormwood Products Co.
    , Ltd.
    to learn about the development of Chinese medicine and the wormwood products industry.
     
      The general secretary said that in the past, the Chinese nation has relied on Chinese medicine to treat illnesses and save people for thousands of years.
    Especially after fighting against the new crown pneumonia epidemic, SARS and other major infectious diseases, we have a deeper understanding of the role of Chinese medicine.
    We must develop Chinese medicine, focus on interpreting the principles of Chinese medicine with modern science, and take the road of integrating Chinese and Western medicine.
     
      According to data, Chinese medicine products are mainly divided into Chinese medicinal materials, Chinese medicinal pieces and Chinese patent medicines.
    Among them, Chinese medicinal materials are primary products, and Chinese patent medicines and Chinese medicine pieces are end products that can be used directly.
     
      It is worth noting that for a long time, the state has been vigorously supporting the traditional Chinese medicine decoction pieces industry.
    The use of TCM decoction pieces is not restricted by many medical reform policies, and the development momentum is better than that of proprietary Chinese medicines.
     
      On May 13th, at the High Quality Development Forum of the Chinese Medicine Industry of the National Pharmaceutical Fair, Cyberlan learned that in recent years, the country has vigorously developed Chinese medicine and the favorable policies for Chinese medicine have blown out, such as the "Outline of the Strategic Plan for the Development of Chinese Medicine", "The Law of the People's Republic of China on Traditional Chinese Medicine", "Opinions on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine" and "Several Policies and Measures on Accelerating the Development of Traditional Chinese Medicine with Characteristics.
    "
     
      Among them, the "Outline of the Strategic Planning for the Development of Traditional Chinese Medicine" clarifies the development direction and focus of my country's traditional Chinese medicine in the next 15 years, and promotes the development of Chinese medicine as a national strategy; and the "Traditional Chinese Medicine Law" is my country's first comprehensive and systematic reflection of the characteristics of Chinese medicine.
    Comprehensive laws.
     
      The growth rate of Chinese patent medicine slows down
      The growth rate of Chinese patent medicine slows down
     
      Previously, because proprietary Chinese medicines were subject to “zero mark-up” and the proportion of medicines, doctors’ prescriptions were restricted.
    Some large varieties of Chinese medicines were included in the local supplementary drug list, and the dosage restrictions were more stringent, resulting in the use of proprietary Chinese medicines in medical institutions.
    Both the amount used and the proportion dropped significantly.
     
      However, Cybelan learned at the drug fair that, up to now, many proprietary Chinese medicines have become more concerned about the transfer of approval documents, including cold, gynecological, and digestive varieties.
    Among them, cold-type Chinese patent medicines are more popular.
    Relevant sources said that the compound honeysuckle granules, Xia Sangju granules, and dandelion granules have good curative effects and the well-known varieties will be more popular.
     
      A more critical factor is the epidemic.
    Some people in the industry once told Cyberlan that the new crown epidemic has elevated the position of Chinese patent medicine, because in the first-line treatment, the epidemic has highlighted the role of Chinese medicine in the treatment of epidemic disease, which will make In the long-term plan, forward-looking pharmaceutical companies explore such products and lay out product lines.
     
      If the changes in hospital medication are not obvious enough, then pharmacies have tasted the sweetness more.
    Basic pharmacies all involved to improve the immune system of medicines , whether traditional Chinese medicine drinks, medicine will be subject to people's attention.
    For example, people over the age of 60 began to buy Chinese herbal health teas, medlar, honeysuckle, and Gynostemma pentaphyllum in pharmacies, and others consulted Cordyceps, Dendrobium and other Chinese herbal drinks for nourishing yin and nourishing lungs.
    Pharmacy pharmacy pharmacy drugs drugs drugs
     
      Some research institutions said that in response to the pressure from medical insurance to control costs, Chinese medicine companies can transform innovative Chinese medicines and develop Chinese patent medicines with significant curative effects and fewer competing products, alleviating the pressure of competitive price reduction; transforming ordinary consumer products that are immune to medical insurance, directly avoiding medical insurance control costs Pressure: To transform into a high-quality and low-cost Chinese medicinal material manufacturer, to control costs, and to transmit pressure to lower prices upstream.
    Enterprise business enterprise
     
      Chinese medicine formula particles are good
      Chinese medicine formula particles are good
     
      It is worth noting that the characteristic Chinese herbal medicine pieces represented by Chinese medicine formula granules is one of the development directions of Chinese medicine, because traditional Chinese medicines such as oral Chinese medicine and traditional Chinese medicine pieces are the core opportunities of current Chinese medicine-the national policy guidelines on Chinese medicine encourage traditional usage.
     
      Cyberlan learned from the above-mentioned high-quality development forum of the Chinese medicine industry that Chinese medicine formula granules do not account for the proportion of medicines, medical insurance can be reimbursed, and hospitals can make money.
    Therefore, 80% of hospitals in 2021 will very much recognize and accept such medicines; in addition, , Because most of the formula particles are directly supplied by traditional Chinese medicine factories, and there is no need for hospitals to set up equipment because of the establishment of special dispensing machines.
    Generally speaking, hospitals will prefer them.
    Hospital hospital hospital
     
      At the same time, formula granules can expand the route and scope of drug administration in the diagnosis and treatment plan, increase the diversity of doctors' treatment methods, and make it easier to carry and store, and the safety and efficacy are more guaranteed-this type of drug is compared in terms of quality control.
    Strict, strict testing of indicators such as heavy metal content, pesticide residues, microorganisms, and chemical pollution.
     
      Data show that from 2011 to 2018, my country's sales revenue of Chinese medicine formula granules increased from about 2.
    2 billion yuan to about 16.
    5 billion yuan, a growth rate that far exceeded that of ordinary Chinese medicine decoction pieces and proprietary Chinese medicines in the same period.
     
      For domestic Chinese medicine companies, the epidemic has brought opportunities for the development of Chinese medicine.
     
      China Traditional Chinese Medicine released its annual report.
    In 2020, the company's performance reached a new high.
    The positive growth in operating performance under the epidemic was mainly due to the active resumption of work and production during the epidemic and the grasp of development opportunities in the Chinese medicine industry.
    Traditional Chinese medicine formula granules are the company's core business.
    In 2020, its business turnover will be approximately 10.
    01 billion yuan, accounting for 67.
    6% of the total turnover.
    Due to the impact of the epidemic, growth has slowed down, with a year-on-year increase of 8.
    5%.
    However, during the epidemic, the company took the initiative to leverage its advantages in formula particles and increased its investment in dispensing machines and the development of medical customers.
    In the second half of the year, its operations picked up, and its turnover increased by 16.
    9% over the same period and 19.
    1% over the first half of the year.
    Medicine Medicine Medicine
     
      To a certain extent, now is the golden age of the development of Chinese medicine.
    The epidemic has pushed the position of Chinese medicine, and formula particles are gradually being released.
    Some pharmaceutical companies have seized the opportunity to achieve rapid growth.
    The words of the General Secretary this time are another clear signal.
    As the favorable Chinese medicine policy is gradually implemented, it is expected that the market scale will usher in a new wave of growth.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.